TRiCares GmbH and SAS
France, FR · 4 known investors
TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation. The company runs clinical studies across Europe and the US targeting structural heart institutions and cardiac patients.
Founders & leadership
AE
Ahmed ElmouelhiPresident & CEO
EG
Esther GerteisSenior VP Medical & Regulatory Affairs
ML
Michael LitzenburgerVP R&D